Clinical Trials

Bergstrom Eye Research is devoted to the efficient management of Phase II, III, and IV clinical trials. Our mission is to adhere to a teamwork model that fosters creativity and provides the highest level of ethical standards and quality results to patients and customers in a timely and efficient manner. We will work in conjunction with Bergstrom Eye & Laser Clinic to provide opportunity to our customers and community in working to improve the quality of life. Bergstrom Eye Research provides quality care to one of the few ophthalmology research sites in the Midwest. Our team consists of highly qualified and experienced staff with a history of managing diversified optical conditions and disease states.

Ocular Hypertension or Open-Angle Glaucoma

Objective: Evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 2 dose strengths of sustained-release drug therapy after initial and repeated administration.

https://clinicaltrials.gov/ – Treatment of Open-Angle Glaucoma & Ocular Hypertension

Phase: 3

Gender: Both Male and Female

Age: 18 years or older

Duration: 22 months (26 visits)

*Patients will receive study medication at no charge, will be compensated for their time and will receive medical care and examinations at no cost for the entirety of the study.

Dry Eye Disease

Objective: Assess the safety and efficacy of an investigational ophthalmic suspension.

https://clinicaltrials.gov/ – Treatment of Dry Eye Disease

Phase: 3

Gender: Both Male and Female

Age: 18 years or older

Duration: 28 days (4 visits)

*Patients will receive study medication at no charge, will be compensated for their time and will receive medical care and examinations at no cost for the entirety of the study.

Ocular Hypertension or Open-Angle Glaucoma

Objective: Assess the efficacy of an investigational product to that of Latanoprost, 0.005%.

https://clinicaltrials.gov/ – Treatment of Open-Angle Glaucoma & Ocular Hypertension

Phase: 3

Gender: Both Male and Female

Age: 18 years or older

Duration: 12 months (9 visits)

*Patients will receive study medication at no charge, will be compensated for their time and will receive medical care and examinations at no cost for the entirety of the study.

Non-infectious Anterior Segment Uveritis

Objective: Assess the efficacy of ocular iontophoresis via investigational drug delivery system.

https://clinicaltrials.gov/ – Treatment of Anterior Uveitis

Phase: 3

Gender: Both Male and Female

Age: 12 to 85 years of age

Duration: 56 days (6 visits)

*Patients will receive study medication at no charge, will be compensated for their time and will receive medical care and examinations at no cost for the entirety of the study.

Macular Edema Associated with Non-infectious Uveitis

Objective: Assess the efficacy of a drug delivery system as shown by a change from baseline visual acuity and mean change of edema.

https://clinicaltrials.gov/ – Treatment of Macular Edema associated with Uveitis

Phase: 3

Gender: Both Male and Female

Age: 18 years or older

Duration: 27 weeks (8 visits)

*Patients will receive study medication at no charge, will be compensated for their time and will receive medical care and examinations at no cost for the entirety of the study.

Non-infectious Anterior Uveitis

Objective: Determine the efficacy, safety and tolerability of non-invasive drug delivery platform for topical administration.

https://clinicaltrials.gov/ – Treatment of Anterior Uveitis

Phase: 1 / 2

Gender: Both Male and Female

Age: 18 years or older

Duration: 30 days (6 visits)

*Patients will receive study medication at no charge, will be compensated for their time and will receive medical care and examinations at no cost for the entirety of the study.

Uveitis Clinical Trial

We are conducting a clinical research study for patients with active or controlled non-infectious intermediate, posterior, or panuveitis. Patients will receive study medication at no charge and be compensated for their time and travel expenses.

Glaucoma Clinical Trial

We are conducting a clinical research study for patients with glaucoma. Compensation for time and travel is provided.

Anterior Iritis/Uveitis Clinical Trial

We are conducting a clinical research study for patients with anterior uveitis. Patients will receive study medication at no charge and be compensated for their time and travel expenses.

If you have any of the following conditions, please contact us to discuss how we can provide proper eye care and appropriate clinical trials for these particular eye disorders.

  • Dry Eye
  • wAMD (Wet Age-Related Macular Degeneration)
  • Iritis
  • Uveitis
  • Glaucoma
  • Ocular Hypertension

Bergstrom Eye Research – CenterWatch Profile


If you have further questions or are interested in taking part in one of our clinical trials, contact one of our Clinical Study Managers:

Kristen N. Peterson, CCRC, CCRP, LPN
Clinical Study Manager
kristen@bergstromeye.com
701.478.0061

Brent B. Moen, B.A., CCRC
Clinical Study Manager
brent@bergstromeye.com
701.478.0061

To those viewing as a local provider, if you find that you have a patient population who may benefit by the introduction to new and innovative medications, products and/or delivery systems, we would welcome the opportunity to co-manage their eye care.

We encourage you to join us in providing the finest, quality eye care to our community through the introduction of clinical trial participation with the goal of providing patients additional options in regards to their current eye disorders and treatment.

 

A patient may find ClinicalTrials.gov to be a beneficial place to look when seeking treatment that is specific to their personal needs. Often times you will find studies that Bergstrom Eye Research is conducting; however, we encourage you to contact our office at (701) 478-0061 to learn more about our currently enrolling studies.